Search results

• Radretumab
  '''Radretumab''' (pronounced rad-re-tu-mab) is a [[monoclonal antibody]] used in the treatment of certain types of [[cancer]]. It is a ty ...its radioactive properties, and "retumab", a common suffix for monoclonal antibodies.
  1 KB (191 words) - 04:59, 6 February 2024
• Rosmantuzumab
  ...''' (pronunciation: roz-man-too-zoo-mab) is a monoclonal antibody designed for the treatment of certain types of cancer. ...t is a monoclonal antibody, while the "tuz-" stem indicates it is used for tumors.
  1 KB (145 words) - 04:16, 7 February 2024
• Gatipotuzumab
  ...(pronunciation: ga-ti-po-tu-zu-mab) is a [[monoclonal antibody]] designed for the treatment of various types of [[cancer]]. It is a type of [[immunothera ...s a monoclonal antibody, while the infix "-tuzu-" suggests that it targets tumors.
  1 KB (193 words) - 04:19, 7 February 2024
• Andecaliximab
  ...atrix metalloproteinase 9 (MMP-9), a protein often found in high levels in tumors and associated with cancer progression. ...nomenclature of monoclonal antibodies. The suffix "-mab" indicates it is a monoclonal antibody, while the infix "-lix-" suggests it targets the immune system.
  1 KB (186 words) - 02:35, 7 February 2024
• Tarextumab
  ...tumab''' (pronounced: ta-rex-tu-mab) is a [[monoclonal antibody]] designed for the treatment of [[cancer]]. It was developed by [[Oncomed Pharmaceuticals] ...ntibody, 'tu' indicates it targets tumors, and 'rex' is a unique stem used for the specific antibody.
  2 KB (203 words) - 04:53, 6 February 2024
• Istiratumab
  ...b''' (pronounced as is-ti-ra-tu-mab) is a [[monoclonal antibody]] designed for the treatment of [[cancer]]. It is a type of [[biological therapy]] that ta ...INN) system for monoclonal antibodies. The "-mab" suffix indicates it is a monoclonal antibody, while the "tira" infix suggests it targets the [[tumor]]s.
  1 KB (197 words) - 17:46, 6 February 2024
• Girentuximab
  ...ab''' (pronounced: gi-ren-tux-i-mab) is a [[monoclonal antibody]] designed for the treatment of [[renal cell carcinoma]], a type of [[kidney cancer]]. It ..."-tuxi-" indicates that it targets tumors, and "-mab" denotes that it is a monoclonal antibody.
  1 KB (202 words) - 23:45, 6 February 2024
• Ertumaxomab
  ...nunciation]]: /ɛrˈtjuːmæksɵmæb/) is a [[tri-functional antibody]] designed for the treatment of [[cancer]]. It is unique in its ability to bind three diff ..."maximus", meaning "greatest". The "-mab" suffix is common in [[monoclonal antibodies]], indicating the drug's classification.
  1 KB (181 words) - 17:54, 6 February 2024
• Sibrotuzumab
  ...'' (pronunciation: si-bro-tu-zu-mab) is a [[monoclonal antibody]] designed for the treatment of certain types of [[cancer]]. It was developed by [[Boehrin ...icates its tumor specificity, and "-mab" is a common suffix for monoclonal antibodies.
  1 KB (172 words) - 02:23, 7 February 2024
• Tacatuzumab tetraxetan
  ...on: ta-cat-uh-zoo-mab tet-ra-xe-tan) is a [[monoclonal antibody]] designed for the treatment of [[cancer]]. It is also known as '''CC49-deltaCH2'''. ...where "taca-" refers to the target, "tuzumab" is a stem used for humanized antibodies, and "tetraxetan" refers to the chelating agent used in the drug.
  2 KB (214 words) - 06:16, 11 February 2024
• Emibetuzumab
  ...pronunciation: em-ee-bet-oo-zoo-mab) is a [[monoclonal antibody]] designed for the treatment of various types of [[cancer]]. It is currently under investi ...at the drug targets [[tumors]], and the suffix "-mab" denotes that it is a monoclonal antibody.
  2 KB (227 words) - 00:13, 7 February 2024
• Abituzumab
  ...ab''' (pronounced as a-bi-tu-zu-mab) is a [[monoclonal antibody]] designed for the treatment of various [[cancer]] types and [[fibrosis]]. It is currently ...em for pharmaceutical substances. The "-mab" suffix indicates that it is a monoclonal antibody, while the "tuzu-" stem suggests its action against [[tumor]]s.
  1 KB (162 words) - 23:33, 3 February 2024
• Olaratumab
  ...tumab''' (pronounced o-lar-a-tu-mab) is a [[monoclonal antibody]] designed for the treatment of certain types of [[cancer]]. It is also known by its trade ...Latin "Ola", meaning "wave", and "Ratumab", a common suffix for monoclonal antibodies. The "wave" signifies the drug's ability to target and attack cancer cells,
  2 KB (182 words) - 04:47, 6 February 2024
• Lumretuzumab
  ...'' (pronounced loom-reh-too-zoo-mab) is a [[monoclonal antibody]] designed for the treatment of [[cancer]]. It is a type of [[biological therapy]] that ta ...indicates that it is a monoclonal antibody, while "lum-" is a prefix used for substances related to the [[immune system]].
  1 KB (200 words) - 02:32, 7 February 2024
• Vitaxin
  '''Vitaxin''' (pronounced vih-TAX-in) is a [[monoclonal antibody]] that is being studied in the treatment of certain types of [[can ...inding to integrin, Vitaxin can block the growth of new blood vessels that tumors need to grow and spread. This makes it a type of [[angiogenesis inhibitor]]
  2 KB (244 words) - 04:07, 5 February 2024
• Urelumab
  '''Urelumab''' (pronounced: yoo-REH-loo-mab) is a fully human monoclonal antibody that is designed to bind to the CD137 protein, which is a costimul ...e the "u-" prefix denotes that it is fully human. The "relu-" stem is used for agents that interact with the immune system.
  2 KB (236 words) - 14:15, 5 February 2024
• Racotumomab
  ...Raco", meaning "to fight", and "tumomab", a common suffix for [[monoclonal antibodies]] used in cancer treatment. ...tumomab can help to slow the growth of cancer cells and potentially shrink tumors.
  1 KB (190 words) - 17:34, 6 February 2024
• Carlumab
  ...mæb/), also known as '''CNTO 888''', is a [[monoclonal antibody]] designed for the treatment of [[cancer]] and [[inflammatory diseases]]. It was developed ...rce of the monoclonal antibody, and "mab" is indicative of its status as a monoclonal antibody.
  1 KB (186 words) - 04:27, 5 February 2024
• Intetumumab
  '''Intetumumab''' (pronunciation: in-teh-too-moo-mab) is a type of [[monoclonal antibody]] that is being studied in the treatment of certain types of [[can ...an]], "mu" refers to [[mus]], and "mab" is indicative of its status as a [[monoclonal antibody]].
  1 KB (199 words) - 17:54, 6 February 2024
• Emactuzumab
  ...''' (pronunciation: e-mac-tu-zu-mab) is a [[monoclonal antibody]] designed for the treatment of various [[cancer]] types. It is developed by [[Roche]], a ...mactu-" refers to the target, and "-mab" is a common suffix for monoclonal antibodies.
  1 KB (166 words) - 14:42, 6 February 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)